Back to All Events

Science Board to the FDA

On Tuesday, November 15, 2016, the Science Board to the US Food and Drug Administration (SBFDA) heard reports from the FDA and discussed topics including: 1. Strategic goals for regulatory science at the Center for Biologics Evaluation and Research (CBER); 2. Progress updates on FDA’s Opioid Action Plan and the Bovine Heparin Initiative; 3. Response from the Office of Scientific Professional Development to the Science Board’s report on the Commissioner’s Fellowship Program; 4. Report from the Scientific Engagement Subcommittee; and 5. Report from the Food Emergency Response Network Cooperative Agreement Program Evaluation Subcommittee.

Earlier Event: November 7
Risk Communication Advisory Committee
Later Event: November 17
Blood Products Advisory Committee